Freshfields Bruckhaus Deringer has been lending its support to a research team led by Swiss historian and President of the German Historical Museum, Prof Dr Raphael Gross, in reviewing and verifying the previous provenance research
Tags :dx1
KPMG Switzerland and KPMG UK announced that their respective partnerships had voted overwhelmingly in favor of merging their partnerships, creating a new USD 4.4 billion business, working across audit, tax and legal, and advisory. Homburger acted
MLL promoted Andrea Schäffler (pictured left) and Marc Baumberger (pictured right) to Senior Associates. Andrea Schäffler Andrea Schäffler is part of MLL’s IP team. She represents and advises clients in all
Walder Wyss advised Enantios, an Eidgenössische Technische Hochschule Zürich (ETH) Zurich deep-tech Spin-off, on the completion of its seed financing round. The Enantios technology, developed over a five year research project at ETH
Niederer Kraft Frey (“NKF”) advised SIX listed CPH Chemie + Papier Holding (CPH) on the separation of its paper manufacturing business and related real estate in Perlen from its chemistry and packaging activities by way of
Kellerhals Carrard advised Kasparund, a FinTech company and spin-off of University of St. Gallen and ETH Zurich, on its strategic partnership with Avaloq, a of front-to-back software and services provider. Concurrently with the strategic partnership,
Walder Wyss advised Helvetia on a successfully placed CHF 230 million senior bond with maturity in 2034 and a 1.95% coupon. The bond, guaranteed by Helvetia, will be used for general corporate purposes, including possible refinancings of outstanding
Kellerhals Carrard advised Helanis, supported by a swiss management buy-in team, on Schaltag Group’s acquisition, consisting of Schaltag AG in Effretikon (CH), Schaltag CZ s.r.o in Ústí nad Orlicí (CZ), PAVIS Engineering
Vischer advised BID Equity on Realview’s acquisition, a developer and software distributor for the Swiss construction industry. Founded in 2013 and based in Zurich, Realview, with it stried-and-tested software solutions, operates a decisive contribution to
Homburger advised Biopas on its sale to Swixx Biopharma, a swiss-based global commercial platform focusing on guaranteeing access to innovative medicines worldwide. The founders of Biopas will become shareholders of Swixx Biopharma. The transaction is
